Trials / Completed
CompletedNCT00245609
Trial of Pregabalin, Alprazolam, and Placebo in Subjects With Anxiety Prior to Dental Procedure
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial Of The Anxiolytic Efficacy Of Pregabalin And Alprazolam IR In Subjects With Anxiety Prior To Dental Procedure
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 90 (planned)
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of the trial is to assess how effective pregabalin, alprazolam, and placebo are at reducing anxiety levels of subjects who take a dose of these treatments 4 hours before a scheduled dental procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Pregabalin | |
| DRUG | Alprazolam | |
| DRUG | Placebo |
Timeline
- Start date
- 2006-01-01
- Completion
- 2006-10-01
- First posted
- 2005-10-28
- Last updated
- 2021-01-22
Locations
9 sites across 2 countries: Germany, United Kingdom
Source: ClinicalTrials.gov record NCT00245609. Inclusion in this directory is not an endorsement.